Skip to content

Verougynex: what changed

BE 1029.198.605Other company

Position among the sector peers

What moved

Only one financial year

Comparing needs two financial years with figures read. This company has one.

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€26,249 to €35,020

Midpoint €29,904 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €8,640
Capitalised earnings €43,857 to €61,400
Indication €26,249 to €35,020

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€8,640
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€8,640

Capitalised earnings

net result for the year (9904)
2025
€6,140
Average result
€6,140
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€43,857 / €51,167 / €61,400

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.